Management of adults with congenital heart disease: an increasing problem

J Somerville1

  • 1GUCH Unit, Royal Brompton Hospital, London, United Kingdom.

Insights

Adults with congenital heart defects (ACHD) require specialized care. Centralizing these patients in expert centers improves outcomes for complex cardiac conditions and arrhythmias.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Adult Cardiology

Background:

  • Growing population of adults with congenital heart defects (ACHD) requires specialized superspecialist care.
  • Complex congenital heart defects and arrhythmias are common reasons for hospitalization in ACHD patients.
  • Current care models often lead to suboptimal medical management for ACHD patients.

Purpose of the Study:

  • To highlight the unmet needs of adult congenital heart patients.
  • To advocate for the centralization of ACHD care in dedicated expert centers.
  • To emphasize the importance of specialized training for cardiologists and surgeons managing ACHD.

Main Methods:

  • Review of current challenges in ACHD care.
  • Analysis of common cardiologic reasons for admission (arrhythmias, atrial flutter).
  • Identification of essential components for optimal ACHD management.

Main Results:

  • Arrhythmias are the most frequent cause of hospital admission in ACHD patients.
  • ACHD patients with complex defects and those undergoing cardiac surgery require specialized expertise.
  • Centralization of care in dedicated centers is crucial for concentrating expertise and improving outcomes.

Conclusions:

  • ACHD patients need dedicated centers with multidisciplinary teams trained in congenital and adult heart disease.
  • Improved transition of care, specialized interventions, and at-risk pregnancy services are essential.
  • Centralizing care, despite financial and bureaucratic barriers, is vital for providing optimal management for this unique patient population.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...